Contacts, documents and full notice history are available with a subscription.
Solicitation Due Soon 1 notice 10 documents

Protein ENGineering (PENG) DARPA-PS-26-129

Solicitation DARPA-PS-26-129 Copied Notice ID be313c6423e841ae9572a0878b3d9bbb Copied DEPT OF DEFENSE — DEF ADVANCED RESEARCH PROJECTS AGCY
SAM.gov
Posted
Aug 07, 2026
Deadline
Oct 19, 2026
Set-aside
None
NAICS
541714
PSC
AC12

Summary

AI-generated · Aug 07, 2026

Develop a multifunctional, target-agnostic platform for precise, programmable editing of endogenous proteins, aiming to transform proteome engineering from a collection of isolated tools into a universal, software-defined discipline.

The platform should be composed of modular targeting components, generalizable effector chemistries, and multiplexed control systems. Rather than developing single-target tools, integrate novel splicing, ligation, and co-translational techniques to directly recognize, modify, and rewrite endogenous proteins within complex biological architectures. Teams may pursue multiple technical paths, advancing from foundational validation to robust demonstrations of efficacy, with ultimate validation in high-fidelity cellular models (e.g., organoids) to show a tissue-level proof-of-concept.

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the development of a multifunctional, target-agnostic platform for precise, programmable editing of endogenous proteins. The goal of the Protein ENGineering (PENG) program is to transition proteome engineering from a collection of isolated, bespoke tools into a universal, software-defined discipline. The PENG program will establish a comprehensive, integrated platform composed of modular targeting, generalizable effector chemistries, and multiplexed control systems. Rather than developing isolated, target-specific tools, performers will integrate novel splicing, ligation, and co-translational techniques to directly recognize, modify, and rewrite endogenous proteins within complex biological architectures. Performers may explore multiple technical paths, progressively advancing their approaches from foundational validation to robust demonstrations of efficacy. Ultimately, this integrated platform will be validated in high-fidelity cellular models (e.g., organoids), to provide an integrated proof-of-concept at the tissue level.

From Solicitation posted on Aug 07, 2026

Notice history

1
  1. Solicitation LATEST Posted Aug 07, 2026 View

Details

Solicitation number DARPA-PS-26-129
Notice ID be313c6423e841ae9572a0878b3d9bbb
Notice type Solicitation
Product / Service (PSC) AC12
NAICS 541714
Archive date Nov 18, 2026

Award Information

Not yet awarded

Contacts

primary
BAA Coordinator

Email

Agency

DEPT OF DEFENSE
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
DEF ADVANCED RESEARCH PROJECTS AGCY

Dates

Posted Aug 07, 2026 1 day ago
Last Updated Aug 07, 2026 9 hours ago
Due Oct 19, 2026 2 months from now